Stratton John G bought ABT
March 31, 2026 · Form 4 insider transaction
Stratton John G bought 382 shares of Abbott Laboratories at $102.67 per share, a transaction worth $39.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
382
Price
$102.67
Total value
$39.2K
InsiderStratton John G
RoleOfficer, Director
CompanyAbbott Laboratories (ABT)
SecurityStock Equivalent Units
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after13,489
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.; Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.